EPS Bio Technology EV/FCF

Mitä EPS Bio Technology tekee? EPS Bio Technology Corp, listed on the Taiwan Stock Exchange with ticker 4183.TWO and ISIN TW0004183009, is headquartered in Baoshan, Taiwan. The company operates within the Health Care sector, specifically in the Health Care industry. It has a workforce of 123 employees. EPS Bio Technology Corp completed its initial public offering (IPO) on November 13, 2012. The company's primary business activities involve the development and manufacture of blood glucose monitoring systems, as well as the development and sales of various medical and related medical equipment. Its main product lines include blood glucose testers, blood glucose test strips, and electric breast pumps. The firm primarily distributes its products to international markets, with a focus on Europe, North America, and other regions in Asia. The company's official website is http://www.epsbio.com.tw/. EPS Bio Technology Corp does not disclose specific financial figures or additional details about its operations beyond the provided information. The company is based in Baoshan, Hsinchu, though the source description mentions Hsinchu as the headquarters location, which is consistent with the city provided in the data. The company's operations are centered around medical technology, with an emphasis on diagnostic and consumer health products. EPS Bio Technology on yksi Eurpooliin suosituimmista yhtiöistä.